In breast cancer, for instance, CSCs are commonly identified by the markers CD44+/CD24−/low and ALDH+ (aldehyde dehydrogenase), which are associated with their ability to initiate tumor formation and sustain tumor growth [34]. This evidence concerns the gene CD44 and breast carcinoma.